Significance of prostate-specific antigen after radical prostatectomy

International Journal of Urology

Volumn 4, Issue 5, 1997, Pages 461-466

  Hachiya, Takahiko ^a   Endo, Makoto ^a   Nogaki, Joji ^a   Ishida, Hajime ^a   Okada, Kiyoki ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Prostate cancer; Prostate specific antigen; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC VALUE; HUMAN; LYMPH NODE METASTASIS; MALE; MINIMAL RESIDUAL DISEASE; PATIENT MONITORING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RELAPSE; SEMINAL VESICLE; TREATMENT OUTCOME;

EID: 0030708957     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.1997.tb00286.x     Document Type: Article

References (19)

1. Jewett HJ, Bridge RW, Gray GF Jr, Shelly WM. The palpable nodule of prostate cancer. Results 15 years after radical excision. JAMA 1968;203:403-406.
2. Paulson DF, Moul JW, Walther PJ. Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results. J Urol 1990;144:1180-1184.
3. Jewett HJ. The present status of radical prostatectomy for stage A and B prostate cancer. Urol Clin N Amer 1975;2:105-124.
4. Schellhammer PF. Radical prostatectomy for carcinoma of the prostate and 15 year analysis of survival and local control. J Urol 1986 (part 2);135:247A (abstr 574).
5. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991;145:907-923.
6. Stamey TA, Kabalin JN, McNeal JE, Johnstone IM, Freiha F, Redwine EA, Yang N. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. Radical prostatectomy treated patients. J Urol 1989;141:1076-1083.
7. Oesterling JE, Chan DW, Epstein JI, Kimball AW Jr, Bruzek DJ, Rock RC, Brendler CB, Walsh PC. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol 1988;139:766-772.
8. Lange PH, Ercole CJ, Lightner DH, Fraley EE, Vessella R, The value of serum prostate specific antigen determinations before and after radical prostatectomy. J Urol 1989;141:863-872.
9. Lightner DJ, Lange PH, Reddy PK, Moore L. Prostate specific antigen and local recurrence after radical prostatectomy. J Urol 1990;144:921-926.
10. Japanese Urological Association, The Japanese Pathological Society. General rules for clinical and pathological studies on prostatic cancer. 2nd ed. Tokyo: Kanehara Publishers, 1992:66-85.
11. Stein A, deKernion JB, Smith RB, Dorey F, Patel H. Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer. J Urol 1992;147:942-946.
12. Hudson MA, Bahnson RR, Catalona WJ. Clinical use of prostate specific antigen in patients with prostate cancer. J Urol 1989;142:1011-1017.
13. Stamey TA, Graves HCB, Wehner N, Ferrari M, Freiha FS. Early detection of residual prostate cancer after radical prostatectomy by an ultrasensitive assay for prostate specific antigen. J Urol 1993;149:787-792.
14. Israeli RS, Miller WH Jr, Su SL, Samadi DS, Powell CT, Heston WDW, Wise GJ, Fair WR. Sensitive detection of prostatic hematogenous tumor cell dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reaction. J Urol 1995;153:573-577.
15. Stamey TA, Kabalin JN, Ferrari M, Yang N. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. Anti-androgen treated patients. J Urol 1989;141:1088-1090.
16. Goldrath DE, Messing EM. Prostate specific antigen not detectable despite tumor progression after radical prostatectomy. J Urol 1989;142:1082-1084.
17. Csapo Z, Brand K, Walther R, Fokas K. Comparative experimental study of the serum prostate specific antigen and prostatic acid phosphatase in serially transplantable human prostatic carcinoma lines in nude mice. J Urol 1988;140:1032-1038.
18. Morgan WR, Zinke H, Rainwater LM, Myers RP, Klee GG. Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: impact of adjuvant treatment (hormonal and radiation). J Urol 1991;145:319-323.
19. Cooper EH, Armitage TG, Robinson MRG, Newling DWW, Richards BR, Smith PH, Denis L, Sylvester R. Prostatic specific antigen and prediction of prognosis in metastatic prostate cancer. Cancer 1990;66(suppl): 1025-1028.